Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Altech Advanced Materials And 2 Other Promising Penny Stocks

In This Article:

Global markets have recently experienced a mixed performance, with U.S. consumer confidence declining and major stock indexes showing moderate gains in a holiday-shortened week. In such fluctuating market conditions, investors often look for opportunities that may not be immediately apparent, such as those offered by penny stocks. Though the term 'penny stock' might sound outdated, these investments can still provide growth potential through smaller or newer companies with strong financial health.

Top 10 Penny Stocks

Name

Share Price

Market Cap

Financial Health Rating

DXN Holdings Bhd (KLSE:DXN)

MYR0.515

MYR2.56B

★★★★★★

Embark Early Education (ASX:EVO)

A$0.765

A$140.36M

★★★★☆☆

Datasonic Group Berhad (KLSE:DSONIC)

MYR0.41

MYR1.14B

★★★★★★

Hil Industries Berhad (KLSE:HIL)

MYR0.895

MYR297.09M

★★★★★★

ME Group International (LSE:MEGP)

£2.05

£772.37M

★★★★★★

Bosideng International Holdings (SEHK:3998)

HK$3.88

HK$44.38B

★★★★★★

LaserBond (ASX:LBL)

A$0.56

A$65.64M

★★★★★★

Begbies Traynor Group (AIM:BEG)

£0.948

£149.54M

★★★★★★

Lever Style (SEHK:1346)

HK$0.86

HK$545.92M

★★★★★★

Secure Trust Bank (LSE:STB)

£3.62

£69.04M

★★★★☆☆

Click here to see the full list of 5,829 stocks from our Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Altech Advanced Materials

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Altech Advanced Materials AG is an investment company focused on making capital investments and partnerships, with a market cap of €18.86 million.

Operations: The company generates revenue from the manufacture of testliners, amounting to €0.11 million.

Market Cap: €18.86M

Altech Advanced Materials AG, with a market cap of €18.86 million, is pre-revenue, generating only €0.11 million from testliners. Recent activities include a follow-on equity offering that raised €3.51 million, indicating efforts to bolster its cash position amid ongoing unprofitability and declining earnings over the past five years. The company has experienced significant shareholder dilution and increased debt levels, with short-term assets covering short-term liabilities but not long-term ones. Despite these challenges, Altech maintains an experienced management team and board of directors while navigating high share price volatility in the German market.

DB:AMA Financial Position Analysis as at Dec 2024
DB:AMA Financial Position Analysis as at Dec 2024

Henan Jinyuan Hydrogenated Chemicals

Simply Wall St Financial Health Rating: ★★★★★☆